TITLE
Dual inhibition of Src and MEK decreases the growth of human ovarian cancer cells

ORGANISM
Homo sapiens

SUMMARY
Treatment of established lines and primary ovarian cancer cultures with Src and MEK inhibitors, saracatinib and selumetinib, respectively, showed target kinase inhibition and synergistic induction of apoptosis and cell cycle arrest in vitro and tumor inhibition in xenografts.

DESIGN
There are three biological replicates per experimental sample.

PLATFORM
GPL10558 Illumina HumanHT-12 V4.0 expression beadchip

CITATIONS
Has this study been published? Please login to update or notify GEO .
